Hence, the aim of this study was to analyse whether the immunohistochemical expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. This evidence concerns the gene CD44 and renal cell carcinoma.